PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Suddenly, Democrats Are Offended by Nazi Analogies | Townhall

Show Me

Commentary: Why Does the Left Hate Israel? | Georgia Star News

Show Me

CNN Fires Contributor Who Praised Hitler | The Epoch Times

Show Me

Never Forget | “The Rise of Utilitarian Extremism, and How to Recognize It” | Mercola

Show Me

Commentary: Election Integrity and the Jim Crow Slur | Mackubin Thomas Owens

Show Me

Bannon’s War Room | Episode 2230 | Saturday Edition Hour 2 | Recorded October 15, 2022 | Video: 48 Minutes 59 Seconds

Show Me

If not a FOIA, how DID Politico get those sexual assault and service records on Jennifer-Ruth Green? | Hot Air

Show Me

Bannon’s War Room | Episode 2229 | Saturday Edition Hour 1 | Recorded October 15, 2022 | Video: 48 Minutes 58 Seconds

Show Me

Never Forget | Glenn Greenwald Discusses Media’s Disgraceful Coverage of Julian Assange | Video: 12 Minutes 27 Seconds

Show Me

Never Forget | Greenwald Claims Trump Impeached to Stop Assange Pardon, CIA Declassification | Glenn Greenwald

Show Me

Never Forget | “Journalists, lawyers claim CIA spied on them during Assange visit” | The Hill

Show Me

Never Forget | “Julian Assange supporters demanding his release will hold vigils across London today” | Daily Mail

Show Me

Julian Assange | “WikiLeaks founder’s family brings campaign to Mexico” | The New York Post

Show Me

Never Forget | “Graham Phillips: British Reporter Is Exiled and Has His Banking Accounts Frozen for Telling the Truth” | Niall McCrae

Show Me

Never Forget | “Goldman Sachs Teams Up with Google’s ‘Director of Regime Change’ to Influence Global Politics” | Breitbart

Show Me

Never Forget | “FBI Raids DC Home of Oleg Deripaska, Chris Steele’s Former Employer and Central Player in Corrupt FBI Operation Against Donald Trump | Conservative Treehouse

Show Me

Never Forget | “Mitch McConnell Promises To Defend Biden Against Impeachment” | National File

Show Me

Never Forget | “How Journalists Helped Promote the Steele Dossier” | Truth Over News

Show Me

Bannon’s War Room | Episode 2228 | Evening Edition | Recorded October 14, 2022 | Video: 48 Minutes 58 Seconds

Show Me

Nightly News Rebroadcast | October 14, 2022 | Video: 28 Minutes 53 Seconds

Show Me

Never Forget | “FBI Drops Thousands of Pages of Documents on Murdered DNC Operative Seth Rich — This is After They Said They Had Nothing” | The Gateway Pundit

Show Me

Never Forget | “‘F*ck You’: Pink Floyd Co-Founder Rejects Pricey Facebook Deal” | The Daily Caller

Show Me

Never Forget | “Snowden slams Harris, Blinken for celebrating World Press Freedom Day” | The New York Post

Show Me

Never Forget | FBI Releases Documents on Investigation Into Death of Democrat National Committee Worker Seth Rich | The Epoch Times

Show Me

Bannon’s War Room | Episode 2227 | Morning Edition Hour 2 | Recorded October 14, 2022 | Video: 48 Minutes 58 Seconds

Show Me

Bannon’s War Room | Episode 2226 | Morning Edition Hour 1 | Recorded October 14, 2022 | Video: 48 Minutes 57 Seconds

Show Me

Nightly News Rebroadcast | October 13, 2022 | Video: 28 Minutes 53 Seconds

Show Me

Bannon’s War Room | Episode 2225 | Evening Edition | Recorded October 13, 2022 | Video: 48 Minutes 58 Seconds

Show Me

Ukraine’s Kyiv Area Hit By Iranian-Made Kamikaze Drones | The Associated Press

Show Me

Larry Elder: Protests in Iran — the silence of the ‘feminists’ and ‘progressives’ | BizPac Review

Show Me

Pro-Life Protesters Speak Out on FBI Arrest; Alex Jones to Pay Nearly $1 billion for Hoax Claims | NTD Good Morning

Show Me

Bannon’s War Room | Episode 2224 | Morning Edition Hour 2 | Recorded October 13, 2022 | Video: 48 Minutes 58 Seconds

Show Me

Macron urges Putin to ‘return to the table’ on Ukraine | Infowars

Show Me

Rep. Gosar: ‘The Anti-Christian Biden Regime Will be Defeated’ | National File

Show Me

BREAKING: Saudi Arabia Foreign Ministry Confirms Joe Biden Attempted to Coerce Kingdom to Cut Oil Prices Until After Midterm Election | The Gateway Pundit

Show Me

Saudi Arabia Rejects White House Criticism of Oil Output Cuts, Says US Asked for Delay Until Midterms | Epoch Times

Show Me

Tulsi rattles Joe Rogan with prediction that Biden regime policies will lead to ‘World War III and a nuclear holocaust’ | BizPacReview

Show Me

Bannon’s War Room | Episode 2223 | Morning Edition Hour 1 | Recorded October 13, 2022 | Video: 48 Minutes 58 Seconds

Show Me

Bannon’s War Room | Episode 2222 | Evening Edition | Recorded October 12, 2022 | Video: 49 Minutes

Show Me

Nightly News Rebroadcast | October 12, 2022 | Video: 26 Minutes 4 Seconds

Show Me